The pilot platform for cross-border vaccine coverage assessment is developed as the part of the Working task 5 of the European Joint Action on Vaccination (EU‐JAV) project. EU-JAV aims to strengthen cooperation between European countries to fight vaccine-preventable diseases. During 3 years and a half (1st August 2018 – 31st March 2022) and with a total budget of 5,800 k€, the project is developing 8 workpackages to reach its objectives. More information is available at the website of EU-JAV.
The pilot platform for cross-border vaccine coverage assessment aims to provide overview of cross-border MMR vaccination coverage using harmonized estimations of vaccination coverage of MMR1 and MMR2 through an open-source computer algorithm that can be shared and run by regions/ countries with IIS or other similar solutions. The open-source computer altgorithm and instructions for use are available at the project section of this web.
The EU-JAV final conference was organized on 9 March 2022 in Paris, France. It has brought together together key speakers to present the works conducted since 2018 in the field of vaccination. Videos of the event including our video on the presentation of the platform are available at the
“While immunization is one of the most successful public health interventions, coverage has plateaued over the last decade. The COVID-19 pandemic and associated disruptions have strained health systems, with 23 million children missing out on vaccination in 2020, 3.7 million more than in 20... read more.Uploaded at: 13.04.2021
Netherlands and Denmark has delivered test data for Pilot platform! The data covers period until the end of 2020. We invite you to check the visualisations for both countries at Coverage on age and Coverage in Europe section as well as for the each country separately on Countries section. read more.Uploaded at: 13.04.2021